Takara Bio USA, Inc., a wholly owned subsidiary of Takara Bio Inc., announced plans to launch two critical solutions for oncology research. These automated single-cell total RNA-seq and DNA-seq library preparation kits will provide high sample and cell throughput, less hands-on time, and the ability to capture more information...
Matica Biotechnology, Inc., a contract development and manufacturing organization (CDMO) of cell and gene therapies (CGTs), announced the appointment of Paul Kim as chief executive officer (CEO).
As incoming CEO, Kim will manage daily operations and provide strategic direction to Matica Bio as it rapidly expands its capacity and capabilities...
resTOR to be the first longevity clinic nationwide to offer the Company's blood-based epigenetic-genetic cardiovascular disease tests
Cardio Diagnostics Holdings, Inc., an AI-driven precision cardiovascular medicine company, announces that Houston-based resTOR Longevity Clinic will integrate Cardio Diagnostics' solutions into its battery of tests for new patients in its longevity-focused concierge...
The Echo® MS+ system unlocks enhanced high-throughput screening capability by bringing acoustic ejection mass spectrometry (AEMS) approaches to the SCIEX ZenoTOF 7600 system.
SCIEX, a global leader in life science analytical technologies, launches the Echo® MS+ system at SLAS 2024. The system couples proprietary Acoustic Ejection Mass Spectrometry technology and...
Napp Pharmaceuticals Limited, a member of the international network of Mundipharma independent associated companies, announced that the Medicines and Healthcare Products Regulatory Agency (MHRA) has authorised rezafungin for the treatment of invasive candidiasis in adults in Great Britain (GB).
The authorisation was based on positive results from the pivotal ReSTORE...
DELFI and Immunocore enter research collaboration with assay for cancer monitoring in multiple solid tumor types
DELFI Diagnostics, Inc., a developer of accessible blood-based tests that deliver a new way to enhance cancer detection, announced availability of the company's fragmentome-based research use only (RUO) cancer monitoring assay. The DELFI-Tumor Fraction (DELFI-TF)...
Group announces inaugural meeting and charter to promote the use of GenAI in life sciences research and development
ArisGlobal , a leading innovative life sciences technology company and inventor of LifeSphere®, announced the formal constitution of the new GenAI Council, which will meet for the first time this month.
The Global...
Through a Combination of Advanced Imaging and Novel Artificial Intelligence, Latest Diagnostic System for Cervical Cancer Screening Can Help More Accurately Detect Disease, Improve Workflow and Enhance Patient Care
Hologic, Inc. announced that its new Genius™ Digital Diagnostics System with the Genius™ Cervical AI algorithm has received clearance from the...
Newly created position will scale the growth of Beacon's breakthrough technology to understand brain activity, and help accelerate the development of new treatment approaches
Beacon Biosignals, a leading computational neurodiagnostics and EEG analytics company, has appointed David Matthews, PhD, as Chief Business Officer to oversee commercial and strategic activities.
Beacon Biosignals partners with...
The new no-code protocol library and AI-powered protocol generation tools will empower scientists with automated, easy-to-use workflows for genomics, proteomics, cell biology, and synthetic biology
Opentrons Labworks, Inc., a leader in lab automation and makers of accessible lab robotics, announced the launch of its new protocol library, offering plug-and-play protocols...
